| Entry |
|
|---|
| Name |
Semaxanib (USAN/INN) |
|---|
| Formula |
C15H14N2O
|
|---|
| Exact mass |
238.1106
|
|---|
| Mol weight |
238.2845
|
|---|
| Structure |
|
|---|
| Class |
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG01917 Receptor tyrosine kinase inhibitor
|
|---|
| Efficacy |
Antineoplastic, Angiogenesis inhibitor, Receptor tyrosine kinase inhibitor |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07045 | Antineoplastics - protein kinase inhibitors |
|
|---|
| Brite |
Drug groups [BR:br08330]
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG01917 Receptor tyrosine kinase inhibitor
D05819 Semaxanib
Target-based classification of drugs [BR:br08310]
Protein kinases
Receptor tyrosine kinases (RTK)
PDGFR family
KIT (CD117)
D05819 Semaxanib (USAN/INN)
FLT3 (CD135)
D05819 Semaxanib (USAN/INN)
VEGFR family
VEGFR2 (KDR)
D05819 Semaxanib (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 18
1 C8x C 17.9900 -18.9700
2 C8x C 17.9900 -20.3700
3 C8x C 19.1800 -21.0700
4 C8y C 20.4400 -20.3700
5 C8y C 20.4400 -18.9700
6 C8x C 19.1800 -18.2700
7 C2y C 21.7700 -20.7900
8 C5x C 22.5400 -19.6700
9 N1x N 21.7700 -18.5500
10 O5x O 23.9400 -19.6700
11 C2b C 21.7700 -22.1900
12 C8y C 22.9600 -22.8900
13 C8y C 22.9600 -24.2900
14 C1a C 21.7000 -24.9900
15 N4x N 24.2900 -22.4700
16 C8y C 25.1300 -23.5900
17 C8x C 24.2900 -24.7100
18 C1a C 26.5300 -23.5900
BOND 20
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 1
9 8 9 1
10 5 9 1
11 8 10 2
12 7 11 2
13 11 12 1
14 12 13 2
15 13 14 1
16 12 15 1
17 15 16 1
18 16 17 2
19 13 17 1
20 16 18 1
|
|---|
